VALN trades 208.5% below Wall Street's consensus target of $17.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VALN achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Valneva SE (VALN) has a Wall Street consensus price target of $17.00, based on estimates from 3 covering analysts. With the stock currently trading at $5.51, this represents a potential upside of +208.5%. The company has a market capitalization of $522M.
Analyst price targets range from a low of $11.00 to a high of $26.00, representing a 88% spread in expectations. The median target of $14.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, VALN trades at a trailing P/E of -3.0x. Analysts expect EPS to grow +44.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NVAXNovavax, Inc. | $1.8B | $10.78 | $18.00 | +67.0% | Buy | — | 23 |
 DYAIDyadic International, Inc. | $12M | $0.34 | — | — | — | — | — |
 IBRXImmunityBio, Inc. | $9.0B | $8.64 | $14.00 | +62.1% | Buy | — | 5 |
 SIGASIGA Technologies, Inc. | $222M | $3.10 | — | — | Buy | 1.8x | 1 |
 PFEPfizer Inc. | $167.5B | $29.39 | $31.13 | +5.9% | Hold | 9.8x | 40 |
 MRKMerck & Co., Inc. | $362.4B | $146.73 | $160.47 | +9.4% | Buy | 53.0x | 38 |
 GSKGSK plc | $100.8B | $50.33 | $57.95 | +15.1% | Hold | 13.9x | 29 |
 SNYSanofi | $113.0B | $47.04 | $49.00 | +4.2% | Hold | 11.4x | 27 |
 BNTXBioNTech SE | $22.0B | $87.51 | $120.33 | +37.5% | Buy | — | 24 |
 MRNAModerna, Inc. | $100.9B | $254.19 | $132.70 | -47.8% | Hold | — | 29 |
Quick answers to the most common questions about buying VALN stock.
The consensus Wall Street price target for VALN is $17, representing 208.5% upside from the current price of $5.51. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
VALN has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $17 implies 208.5% upside from current levels.
VALN's current price is $5.51 with a consensus target of $17 (208.5% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $26 for VALN, while the most conservative target is $11. The consensus of $17 represents the median expectation. These targets typically reflect 12-month expectations.
VALN is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VALN stock forecast based on 3 Wall Street analysts shows a consensus price target of $17, with estimates ranging from $11 (bear case) to $26 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on VALN, with a "Buy" consensus rating and $17 price target (208.5% upside). 2 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VALN analyst price targets range from $11 to $26, a 88% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $17 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.